DE69431142D1 - Zusammensetzungen und Methoden zur Strukturellen Proteinbestimmung - Google Patents

Zusammensetzungen und Methoden zur Strukturellen Proteinbestimmung

Info

Publication number
DE69431142D1
DE69431142D1 DE69431142T DE69431142T DE69431142D1 DE 69431142 D1 DE69431142 D1 DE 69431142D1 DE 69431142 T DE69431142 T DE 69431142T DE 69431142 T DE69431142 T DE 69431142T DE 69431142 D1 DE69431142 D1 DE 69431142D1
Authority
DE
Germany
Prior art keywords
labeled
protein
amino acid
acid mixture
subjecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69431142T
Other languages
English (en)
Other versions
DE69431142T2 (de
Inventor
Miles Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Martek Biosciences Corp
Original Assignee
Martek Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21764312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69431142(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Martek Biosciences Corp filed Critical Martek Biosciences Corp
Publication of DE69431142D1 publication Critical patent/DE69431142D1/de
Application granted granted Critical
Publication of DE69431142T2 publication Critical patent/DE69431142T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69431142T 1993-02-05 1994-02-07 Zusammensetzungen und Methoden zur Strukturellen Proteinbestimmung Expired - Fee Related DE69431142T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/014,243 US5393669A (en) 1993-02-05 1993-02-05 Compositions and methods for protein structural determinations
PCT/US1994/001329 WO1994018339A1 (en) 1993-02-05 1994-02-07 Compositions and methods for protein structural determinations

Publications (2)

Publication Number Publication Date
DE69431142D1 true DE69431142D1 (de) 2002-09-12
DE69431142T2 DE69431142T2 (de) 2003-10-09

Family

ID=21764312

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69431142T Expired - Fee Related DE69431142T2 (de) 1993-02-05 1994-02-07 Zusammensetzungen und Methoden zur Strukturellen Proteinbestimmung

Country Status (13)

Country Link
US (3) US5393669A (de)
EP (3) EP1191033A3 (de)
JP (4) JPH07506192A (de)
AT (1) ATE221918T1 (de)
AU (2) AU678446B2 (de)
CA (1) CA2129904A1 (de)
DE (1) DE69431142T2 (de)
DK (1) DK0636183T3 (de)
ES (1) ES2181715T3 (de)
FI (1) FI112116B (de)
NO (1) NO943703L (de)
PT (1) PT636183E (de)
WO (1) WO1994018339A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393669A (en) * 1993-02-05 1995-02-28 Martek Biosciences Corp. Compositions and methods for protein structural determinations
US5989827A (en) * 1995-11-14 1999-11-23 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules
US5891643A (en) * 1995-11-14 1999-04-06 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules
WO1997018469A2 (en) * 1995-11-14 1997-05-22 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules
AU7731696A (en) * 1995-11-15 1997-06-05 Martek Corporation Photosynthetic production of stable isotopically labeled recombinant proteins
US6168912B1 (en) 1996-01-23 2001-01-02 Martek Biosciences Corporation Method and kit for making a multidimensional combinatorial chemical library
US6111066A (en) * 1997-09-02 2000-08-29 Martek Biosciences Corporation Peptidic molecules which have been isotopically substituted with 13 C, 15 N and 2 H in the backbone but not in the sidechains
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
WO2000040988A1 (en) * 1998-12-30 2000-07-13 Nycomed Amersham Plc Nmr spectroscopic in vitro assay using hyperpolarization
AU5880800A (en) * 1999-06-25 2001-01-31 Battelle Memorial Institute Use of non-lossy solvents as a means to improve the high-field nmr sensitivity of biological samples
AU2001259470A1 (en) * 2000-05-05 2001-11-20 Purdue Research Foundation Affinity selected signature peptides for protein identification and quantification
US6762041B2 (en) * 2000-05-15 2004-07-13 Ajinomoto Co., Inc. Method for isotope labeling of protein with enzyme
US6882939B2 (en) * 2000-10-20 2005-04-19 Prospect Pharma Rapid determination of protein global folds
WO2002035239A1 (en) * 2000-10-20 2002-05-02 Martek Biosciences Corporation Rapid determination of protein global folds
US20030068651A1 (en) * 2001-03-12 2003-04-10 Cheryl Arrowsmith Multi-target analysis of gene families for chemistry of high affinity and selective small molecules and other therapeutics
US7256047B2 (en) * 2001-05-01 2007-08-14 Board Of Regents, The University Of Texas System Measurement of gluconeogenesis and intermediary metabolism using stable isotopes
WO2003006488A1 (en) * 2001-07-13 2003-01-23 The Regents Of The University Of California In-cell nmr spectroscopy
WO2003025156A2 (en) * 2001-09-18 2003-03-27 Affinium Pharmaceuticals, Inc. Methods and apparatuses for purification
AU2002341862C1 (en) * 2001-09-27 2009-01-29 Purdue Research Foundation Controlling isotope effects during fractionation of analytes
ES2326040T3 (es) 2001-10-19 2009-09-29 Isotechnika Inc. Sintesis de analogos de ciclosporina.
WO2003053910A1 (fr) * 2001-12-19 2003-07-03 Japan Science And Technology Agency Amino acide marque par isotope stable, technique d'integration de cet amino acide dans une proteine cible, technique d'analyse structurelle par irm de proteine et technique de production d'acide fumarique et d'acide tartrique marques par isotope stable a selection de site
US20040072356A1 (en) * 2002-02-20 2004-04-15 Guillermo Senisterra Methods and apparatuses for characterizing stability of biological molecules
US20050079526A1 (en) * 2002-02-20 2005-04-14 Affinium Pharmaceuticals, Inc. Methods and apparatuses for characterizing refolding and aggregation of biological molecules
US20050181464A1 (en) * 2002-04-04 2005-08-18 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from bacteria
US20040033530A1 (en) * 2002-04-08 2004-02-19 Awrey Donald E. High throughput purification, characterization and identification of recombinant proteins
NO20023357D0 (no) * 2002-04-19 2002-07-11 Amersham Health As Blanding
WO2003104430A2 (en) * 2002-06-10 2003-12-18 Prospect Pharma Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
US20040121445A1 (en) * 2002-07-31 2004-06-24 Fabien Marino Cell cultures
US20070184455A1 (en) * 2003-05-16 2007-08-09 Cheryl Arrowsmith Evaluation of spectra
EP1644474B1 (de) 2003-07-11 2012-06-27 Tatiana A. Egorova-Zachernyuk Zusammensetzungen und verfahren zur stabilen isotopmarkierung biologischer verbindungen
WO2005037853A2 (en) * 2003-10-07 2005-04-28 Prospect Pharma Side chain deuterated amino acids and methods of use
CA2544305C (en) 2003-10-31 2011-07-12 Japan Science And Technology Agency Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins
EP2447356B1 (de) 2005-06-07 2016-04-20 DSM Nutritional Products AG Eukaryotische Mikroorganismen zur Herstellung von Lipiden und Antioxidantien
GB0604647D0 (en) 2006-03-08 2006-04-19 Shchepinov Mikhail Stabilized food supplements and their derivatives
EP2043970B1 (de) * 2006-07-05 2018-04-18 Centre National De La Recherche Scientifique (C.N.R.S.) Co-katalysiertes eisen-kupfer-verfahren für kohlenstoff-kohlenstoff- oder kohlenstoff-heteroatom-bindung
MX2009001346A (es) * 2006-08-01 2009-04-17 Ocean Nutrition Canada Ltd Microbios productores de aceite y metodos de modificacion de los mismos.
DE102011007790A1 (de) * 2011-04-20 2012-10-25 Wacker Chemie Ag Verfahren zur Reinigung von L-Cystein
US9873880B2 (en) 2013-03-13 2018-01-23 Dsm Nutritional Products Ag Engineering microorganisms
US20140260586A1 (en) * 2013-03-14 2014-09-18 Schlumberger Technology Corporation Method to perform rapid formation fluid analysis
JP2015067581A (ja) * 2013-09-30 2015-04-13 国立大学法人京都大学 多重共鳴用のプローブ
WO2015070872A1 (en) * 2013-11-13 2015-05-21 Nanonord A/S A method for quantitative determination of nitrogen in an aqueous fluid
CN104030942B (zh) * 2014-06-09 2016-08-24 浙江普洛医药科技有限公司 一种L-α-氨基丁酰胺盐酸盐的制备方法
EP3452078A4 (de) * 2016-05-02 2020-01-22 Retrotope, Inc. Isotopisch modifizierte zusammensetzung und deren therapeutische verwendung
CN107793209A (zh) * 2016-08-30 2018-03-13 泰生科技香港有限公司 稳定性同位素标记植物的专用培养基、其制备方法及用途
JOP20190097A1 (ar) 2016-10-27 2019-04-28 Janssen Pharmaceutica Nv الجلوبولينات المناعية واستخداماتها

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182656A (en) * 1976-09-10 1980-01-08 Johnston Laboratories, Inc. Method for detecting the presence of biologically active agents utilizing 13 C-labeled substrates
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
JPS5811857A (ja) * 1981-07-15 1983-01-22 Yamasa Shoyu Co Ltd アデノシンの定量法
DK0474790T3 (da) * 1989-06-14 1997-07-07 Martek Corp Medier til cellevækst og fremgangsmåde til fremstilling deraf
JP2517688B2 (ja) * 1989-12-25 1996-07-24 日本電子株式会社 ３次元核磁気共鳴スペクトルの対称化処理方法
JPH0446143A (ja) * 1990-06-11 1992-02-17 Hitachi Ltd 同位体多重標識アミノ酸の合成法
US5393669A (en) * 1993-02-05 1995-02-28 Martek Biosciences Corp. Compositions and methods for protein structural determinations
US5478729A (en) * 1994-04-28 1995-12-26 Syntex (U.S.A.) Inc. Immunoassay for homocysteine

Also Published As

Publication number Publication date
FI943745A (fi) 1994-08-15
AU711468B2 (en) 1999-10-14
CA2129904A1 (en) 1994-08-18
EP1191033A3 (de) 2003-07-30
US5393669A (en) 1995-02-28
ES2181715T3 (es) 2003-03-01
AU6236394A (en) 1994-08-29
EP1193271A3 (de) 2004-03-24
FI112116B (fi) 2003-10-31
EP1191033A2 (de) 2002-03-27
WO1994018339A1 (en) 1994-08-18
EP0636183B1 (de) 2002-08-07
JP2004115528A (ja) 2004-04-15
AU3608797A (en) 1997-12-04
EP1193271A2 (de) 2002-04-03
FI943745A0 (fi) 1994-08-15
JP2004113248A (ja) 2004-04-15
NO943703L (no) 1994-11-23
DE69431142T2 (de) 2003-10-09
JP2004125801A (ja) 2004-04-22
EP0636183A1 (de) 1995-02-01
US5627044A (en) 1997-05-06
PT636183E (pt) 2002-11-29
AU678446B2 (en) 1997-05-29
US5817474A (en) 1998-10-06
NO943703D0 (no) 1994-10-04
EP0636183A4 (de) 1997-01-22
DK0636183T3 (da) 2002-12-02
ATE221918T1 (de) 2002-08-15
JPH07506192A (ja) 1995-07-06

Similar Documents

Publication Publication Date Title
DE69431142D1 (de) Zusammensetzungen und Methoden zur Strukturellen Proteinbestimmung
ATE106406T1 (de) Verfahren zur reinigung von vitamin k-abhängigen proteinen.
DE69130113T2 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
ATE420061T1 (de) 13c,15n,2h markierte proteine zur nmr strukturbestimmung und deren herstellung
DE69713374D1 (de) Verfahren zur herstellung von optisch reinen isomeren des formoterols
DE3867046D1 (de) Verfahren zur reinigung von serumalbumin.
DE3773963D1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
ATE159532T1 (de) Verfahren zur reinigung von igg-monoklonalen antikörpern
FI103974B1 (fi) Menetelmä proteiinin puhdistamiseksi
ES2059854T3 (es) Nuevo polipeptido y su produccion.
DE69719382D1 (de) VERFAHREN ZUR HERSTELLUNG VON rDSPA Alpha1
ES2109225T3 (es) Anticuerpos, su produccion y uso.
ATE140225T1 (de) Tritiumarkierte fibrinogen-rezeptor-antagonisten, deren verwendung und verfahren zur ihrer herstellung
KR950000889A (ko) 신규 아미노펩티다제
ATE214359T1 (de) Verfahren zur herstellung von 2- und 4- hydroxymandelsäure
Brown Compositions and methods for protein structural determinations
IT1236225B (it) Metodo per la determinazione della spermina nel siero umano ed altri liquidi biologici.
DE3865389D1 (de) Verfahren zur herstellung von l,l oder d,d oder racemat n6 benzyloxycarbonyl 2,6 diaminopimelinsaeuremonoamid.
ATE187252T1 (de) Verfahren zur herstellung langzeitstabiler klarer seren

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee